Loading…
Reported covered position: Research Analyst, H. Oversight & Govt Reform Ctte; Prof. Staff, S. Homeland Sec. & Govt Affairs Ctte; Prof. Staff, H. Oversight & Govt Reform Ctte; Investigator, S. Judiciary Ctte; Prof. Staff, H. Ways & Means Ctte
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Phair Pricing Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to HHS Proposed Rule Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019 The Prescription Drug Pricing Reduction Act of 2019 (no bill number assigned)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
CVS HEALTH (AND SUBSIDIARIES) via CVS HEALTH (AND SUBSIDIARIES)
2019 · fourth_quarter · Q4
Issues related to employer, small group and individual insurance markets, including surprise billing. H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinates of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Source: Senate LDA
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovate Device Act of 2019
Phair Pricing Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 1614/S. 724, The John S. McCain Opioid Addiction Prevention Act of 2019
Phair Pricing Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Phair Pricing Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to HHS Proposed Rule Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. S. 317/H.R. 1226, The Advancing Care for Exceptional Kids Act of 2019 S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019
Phair Pricing Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to HHS Proposed Rule Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020 S. 317/H.R. 1226, The Advancing Care for Exceptional Kids Act of 2019 S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019
Phair Pricing Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 1614/S. 724, The John S. McCain Opioid Addiction Prevention Act of 2019 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Phair Pricing Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 The Prescription Drug Pricing Reduction Act of 2019 (no bill number assigned)
Prescription Drug Price Transparency Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 1614/S. 724, The John S. McCain Opioid Addiction Prevention Act of 2019 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Prescription Drug Price Transparency Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Prescription Drug Price Transparency Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 The Prescription Drug Pricing Reduction Act of 2019 (no bill number assigned)
Prescription Drug Price Transparency Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to HHS Proposed Rule Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020 S. 317/H.R. 1226, The Advancing Care for Exceptional Kids Act of 2019 S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019
Prescription Drug Price Transparency Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 1614/S. 724, The John S. McCain Opioid Addiction Prevention Act of 2019
Prescription Drug Price Transparency Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to HHS Proposed Rule Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019 The Prescription Drug Pricing Reduction Act of 2019 (no bill number assigned)
Prescription Drug Price Transparency Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovate Device Act of 2019
Prescription Drug Price Transparency Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to HHS Proposed Rule Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. S. 317/H.R. 1226, The Advancing Care for Exceptional Kids Act of 2019 S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019
ACE Kids Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to HHS Proposed Rule Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. S. 317/H.R. 1226, The Advancing Care for Exceptional Kids Act of 2019 S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019
ACE Kids Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to HHS Proposed Rule Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020 S. 317/H.R. 1226, The Advancing Care for Exceptional Kids Act of 2019 S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019
Health Insurance Tax Relief Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to health savings accounts, the health insurance tax, and other taxes included in the Affordable Care Act. S. 80, The Jobs and Premium Protection Act of 2019 S. 172/H.R. 1398, The Health Insurance Tax Relief Act of 2019 H.R. 2213/S. 978, The Work Opportunity Tax Credit and Jobs Act of 2019 S. 1498, The Chronic Disease Management Act of 2019
Health Insurance Tax Relief Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to health savings accounts, the health insurance tax, and other taxes included in the Affordable Care Act. S. 80, The Jobs and Premium Protection Act S. 172/H.R. 1398, The Health Insurance Tax Relief Act of 2019
Health Insurance Tax Relief Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to health savings accounts, the health insurance tax, and other taxes included in the Affordable Care Act. S. 80, The Jobs and Premium Protection Act of 2019 S. 172/H.R. 1398, The Health Insurance Tax Relief Act of 2019 H.R. 2213/S. 978, The Work Opportunity Tax Credit and Jobs Act of 2019 S. 1498, The Chronic Disease Management Act of 2019
Health Insurance Tax Relief Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to health savings accounts, the health insurance tax, and other taxes included in the Affordable Care Act. S. 80, The Jobs and Premium Protection Act of 2019 S. 172/H.R. 1398, The Health Insurance Tax Relief Act of 2019 H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 2213/S. 978, The Work Opportunity Tax Credit and Jobs Act of 2019 S. 1498, The Chronic Disease Management Act of 2019
Protecting Consumer Access to Generic Drugs Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to barriers to generic drug and biosmiliar market entry. H.R. 985, The Fair Access for Safe and Timely Generics Act of 2019 H.R. 1865, Further Consolidated Appropriations Act, 2020 S. 64, The Preserve Access to Affordable Generics Act of 2019 S. 340/H.R. 965, The Creating and Restoring Equal Access to Equivalent Samples Act of 2019 H.R. 1499, The Protecting Consumer Access to Generic Drugs Act of 2019 S. 659, The Biologic Patent Transparency Act of 2019
Protecting Consumer Access to Generic Drugs Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to barriers to generic drug and biosmiliar market entry. H.R. 985, The Fair Access for Safe and Timely Generics Act of 2019 S. 64, The Preserve Access to Affordable Generics Act of 2019 S. 340/H.R. 965, The Creating and Restoring Equal Access to Equivalent Samples Act of 2019 H.R. 1499, The Protecting Consumer Access to Generic Drugs Act of 2019 S. 659, The Biologic Patent Transparency Act of 2019
Protecting Consumer Access to Generic Drugs Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to barriers to generic drug and biosmiliar market entry including pay-for-delay and REMS. H.R. 985, The Fair Access for Safe and Timely Generics Act of 2019 S. 64, The Preserve Access to Affordable Generics Act of 2019 S. 340/H.R. 965, The Creating and Restoring Equal Access to Equivalent Samples Act of 2019 H.R. 1499, The Protecting Consumer Access to Generic Drugs Act of 2019 S. 659, The Biologic Patent Transparency Act of 2019
Protecting Consumer Access to Generic Drugs Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to barriers to generic drug and biosmiliar market entry including pay-for-delay and REMS. H.R. 985, The Fair Access for Safe and Timely Generics Act of 2019 S. 64, The Preserve Access to Affordable Generics Act of 2019 S. 340/H.R. 965, The Creating and Restoring Equal Access to Equivalent Samples Act of 2019 H.R. 1499, The Protecting Consumer Access to Generic Drugs Act of 2019 S. 659, The Biologic Patent Transparency Act of 2019
John S. McCain Opioid Addiction Prevention Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 1614/S. 724, The John S. McCain Opioid Addiction Prevention Act of 2019
John S. McCain Opioid Addiction Prevention Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 1614/S. 724, The John S. McCain Opioid Addiction Prevention Act of 2019 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Further Consolidated Appropriations Act, 2020
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to health savings accounts, the health insurance tax, and other taxes included in the Affordable Care Act. S. 80, The Jobs and Premium Protection Act of 2019 S. 172/H.R. 1398, The Health Insurance Tax Relief Act of 2019 H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 2213/S. 978, The Work Opportunity Tax Credit and Jobs Act of 2019 S. 1498, The Chronic Disease Management Act of 2019
Further Consolidated Appropriations Act, 2020
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovate Device Act of 2019
Further Consolidated Appropriations Act, 2020
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing. H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinates of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Further Consolidated Appropriations Act, 2020
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to barriers to generic drug and biosmiliar market entry. H.R. 985, The Fair Access for Safe and Timely Generics Act of 2019 H.R. 1865, Further Consolidated Appropriations Act, 2020 S. 64, The Preserve Access to Affordable Generics Act of 2019 S. 340/H.R. 965, The Creating and Restoring Equal Access to Equivalent Samples Act of 2019 H.R. 1499, The Protecting Consumer Access to Generic Drugs Act of 2019 S. 659, The Biologic Patent Transparency Act of 2019
Further Consolidated Appropriations Act, 2020
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Prescription Drug STAR Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Prescription Drug STAR Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 1614/S. 724, The John S. McCain Opioid Addiction Prevention Act of 2019 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Prescription Drug STAR Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 The Prescription Drug Pricing Reduction Act of 2019 (no bill number assigned)
Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 1614/S. 724, The John S. McCain Opioid Addiction Prevention Act of 2019 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 The Prescription Drug Pricing Reduction Act of 2019 (no bill number assigned)
Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
To amend the Internal Revenue Code of 1986 to make the work opportunity credit permanent.
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to health savings accounts, the health insurance tax, and other taxes included in the Affordable Care Act. S. 80, The Jobs and Premium Protection Act of 2019 S. 172/H.R. 1398, The Health Insurance Tax Relief Act of 2019 H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 2213/S. 978, The Work Opportunity Tax Credit and Jobs Act of 2019 S. 1498, The Chronic Disease Management Act of 2019
To amend the Internal Revenue Code of 1986 to make the work opportunity credit permanent.
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to health savings accounts, the health insurance tax, and other taxes included in the Affordable Care Act. S. 80, The Jobs and Premium Protection Act of 2019 S. 172/H.R. 1398, The Health Insurance Tax Relief Act of 2019 H.R. 2213/S. 978, The Work Opportunity Tax Credit and Jobs Act of 2019 S. 1498, The Chronic Disease Management Act of 2019
To amend the Internal Revenue Code of 1986 to make the work opportunity credit permanent.
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to health savings accounts, the health insurance tax, and other taxes included in the Affordable Care Act. S. 80, The Jobs and Premium Protection Act of 2019 S. 172/H.R. 1398, The Health Insurance Tax Relief Act of 2019 H.R. 2213/S. 978, The Work Opportunity Tax Credit and Jobs Act of 2019 S. 1498, The Chronic Disease Management Act of 2019
More Efficient Tools to Realize Information for Consumers Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to HHS Proposed Rule Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020 S. 317/H.R. 1226, The Advancing Care for Exceptional Kids Act of 2019 S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019
More Efficient Tools to Realize Information for Consumers Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovate Device Act of 2019
More Efficient Tools to Realize Information for Consumers Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 The Prescription Drug Pricing Reduction Act of 2019 (no bill number assigned)
More Efficient Tools to Realize Information for Consumers Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to HHS Proposed Rule Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019 The Prescription Drug Pricing Reduction Act of 2019 (no bill number assigned)
More Efficient Tools to Realize Information for Consumers Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
More Efficient Tools to Realize Information for Consumers Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 1614/S. 724, The John S. McCain Opioid Addiction Prevention Act of 2019 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Prescription Pricing for the People Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the competitive nature of the pharmacy benefit management industry. H.R. 2376/S. 1227, The Prescription Pricing for the People Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Prescription Pricing for the People Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the competitive nature of the pharmacy benefit management industry. H.R. 2376/S. 1227, The Prescription Pricing for the People Act of 2019 The Prescription Drug Pricing Reduction Act of 2019 (no bill number assigned)
Prescription Pricing for the People Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the competitive nature of the pharmacy benefit management industry. H.R. 2376/S. 1227, The Prescription Pricing for the People Act of 2019
Elijah E. Cummings Lower Drug Costs Now Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovate Device Act of 2019
Elijah E. Cummings Lower Drug Costs Now Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to HHS Proposed Rule Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019 The Prescription Drug Pricing Reduction Act of 2019 (no bill number assigned)
Improving Seniors’ Timely Access to Care Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinates of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Improving Seniors’ Timely Access to Care Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing. H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinates of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Improving Seniors’ Timely Access to Care Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinates of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Shop Rx Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to HHS Proposed Rule Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020 S. 317/H.R. 1226, The Advancing Care for Exceptional Kids Act of 2019 S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019
Shop Rx Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 The Prescription Drug Pricing Reduction Act of 2019 (no bill number assigned)
Shop Rx Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovate Device Act of 2019
Shop Rx Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Shop Rx Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 1614/S. 724, The John S. McCain Opioid Addiction Prevention Act of 2019 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Shop Rx Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to HHS Proposed Rule Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019 The Prescription Drug Pricing Reduction Act of 2019 (no bill number assigned)
No Surprises Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing. H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinates of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
No Surprises Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinates of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
No Surprises Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinates of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Improving Transparency and Accuracy in Medicare Part D Spending Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 1614/S. 724, The John S. McCain Opioid Addiction Prevention Act of 2019 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Improving Transparency and Accuracy in Medicare Part D Spending Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to HHS Proposed Rule Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019 The Prescription Drug Pricing Reduction Act of 2019 (no bill number assigned)
Improving Transparency and Accuracy in Medicare Part D Spending Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to HHS Proposed Rule Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. S. 317/H.R. 1226, The Advancing Care for Exceptional Kids Act of 2019 S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019
Improving Transparency and Accuracy in Medicare Part D Spending Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 The Prescription Drug Pricing Reduction Act of 2019 (no bill number assigned)
Improving Transparency and Accuracy in Medicare Part D Spending Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to HHS Proposed Rule Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020 S. 317/H.R. 1226, The Advancing Care for Exceptional Kids Act of 2019 S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019
Improving Transparency and Accuracy in Medicare Part D Spending Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovate Device Act of 2019
Improving Transparency and Accuracy in Medicare Part D Spending Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Improving Transparency and Accuracy in Medicare Part D Spending Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 1614/S. 724, The John S. McCain Opioid Addiction Prevention Act of 2019
CREATES Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to barriers to generic drug and biosmiliar market entry including pay-for-delay and REMS. H.R. 985, The Fair Access for Safe and Timely Generics Act of 2019 S. 64, The Preserve Access to Affordable Generics Act of 2019 S. 340/H.R. 965, The Creating and Restoring Equal Access to Equivalent Samples Act of 2019 H.R. 1499, The Protecting Consumer Access to Generic Drugs Act of 2019 S. 659, The Biologic Patent Transparency Act of 2019
CREATES Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to barriers to generic drug and biosmiliar market entry. H.R. 985, The Fair Access for Safe and Timely Generics Act of 2019 H.R. 1865, Further Consolidated Appropriations Act, 2020 S. 64, The Preserve Access to Affordable Generics Act of 2019 S. 340/H.R. 965, The Creating and Restoring Equal Access to Equivalent Samples Act of 2019 H.R. 1499, The Protecting Consumer Access to Generic Drugs Act of 2019 S. 659, The Biologic Patent Transparency Act of 2019
CREATES Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to barriers to generic drug and biosmiliar market entry. H.R. 985, The Fair Access for Safe and Timely Generics Act of 2019 S. 64, The Preserve Access to Affordable Generics Act of 2019 S. 340/H.R. 965, The Creating and Restoring Equal Access to Equivalent Samples Act of 2019 H.R. 1499, The Protecting Consumer Access to Generic Drugs Act of 2019 S. 659, The Biologic Patent Transparency Act of 2019
CREATES Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to barriers to generic drug and biosmiliar market entry including pay-for-delay and REMS. H.R. 985, The Fair Access for Safe and Timely Generics Act of 2019 S. 64, The Preserve Access to Affordable Generics Act of 2019 S. 340/H.R. 965, The Creating and Restoring Equal Access to Equivalent Samples Act of 2019 H.R. 1499, The Protecting Consumer Access to Generic Drugs Act of 2019 S. 659, The Biologic Patent Transparency Act of 2019
FAST Generics Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to barriers to generic drug and biosmiliar market entry including pay-for-delay and REMS. H.R. 985, The Fair Access for Safe and Timely Generics Act of 2019 S. 64, The Preserve Access to Affordable Generics Act of 2019 S. 340/H.R. 965, The Creating and Restoring Equal Access to Equivalent Samples Act of 2019 H.R. 1499, The Protecting Consumer Access to Generic Drugs Act of 2019 S. 659, The Biologic Patent Transparency Act of 2019
FAST Generics Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to barriers to generic drug and biosmiliar market entry. H.R. 985, The Fair Access for Safe and Timely Generics Act of 2019 H.R. 1865, Further Consolidated Appropriations Act, 2020 S. 64, The Preserve Access to Affordable Generics Act of 2019 S. 340/H.R. 965, The Creating and Restoring Equal Access to Equivalent Samples Act of 2019 H.R. 1499, The Protecting Consumer Access to Generic Drugs Act of 2019 S. 659, The Biologic Patent Transparency Act of 2019
FAST Generics Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to barriers to generic drug and biosmiliar market entry including pay-for-delay and REMS. H.R. 985, The Fair Access for Safe and Timely Generics Act of 2019 S. 64, The Preserve Access to Affordable Generics Act of 2019 S. 340/H.R. 965, The Creating and Restoring Equal Access to Equivalent Samples Act of 2019 H.R. 1499, The Protecting Consumer Access to Generic Drugs Act of 2019 S. 659, The Biologic Patent Transparency Act of 2019
FAST Generics Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to barriers to generic drug and biosmiliar market entry. H.R. 985, The Fair Access for Safe and Timely Generics Act of 2019 S. 64, The Preserve Access to Affordable Generics Act of 2019 S. 340/H.R. 965, The Creating and Restoring Equal Access to Equivalent Samples Act of 2019 H.R. 1499, The Protecting Consumer Access to Generic Drugs Act of 2019 S. 659, The Biologic Patent Transparency Act of 2019
Prescription Pricing for the People Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the competitive nature of the pharmacy benefit management industry. H.R. 2376/S. 1227, The Prescription Pricing for the People Act of 2019
Prescription Pricing for the People Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the competitive nature of the pharmacy benefit management industry. H.R. 2376/S. 1227, The Prescription Pricing for the People Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Prescription Pricing for the People Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to the competitive nature of the pharmacy benefit management industry. H.R. 2376/S. 1227, The Prescription Pricing for the People Act of 2019 The Prescription Drug Pricing Reduction Act of 2019 (no bill number assigned)
Issues related to employer, small group and individual insurance markets, including surprise billing. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinates of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Issues related to employer, small group and individual insurance markets, including surprise billing. H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinates of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Issues related to employer, small group and individual insurance markets, including surprise billing. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinates of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Department of Defense Climate Resiliency and Readiness Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to health savings accounts, the health insurance tax, and other taxes included in the Affordable Care Act. S. 80, The Jobs and Premium Protection Act of 2019 S. 172/H.R. 1398, The Health Insurance Tax Relief Act of 2019 H.R. 2213/S. 978, The Work Opportunity Tax Credit and Jobs Act of 2019 S. 1498, The Chronic Disease Management Act of 2019
Department of Defense Climate Resiliency and Readiness Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to health savings accounts, the health insurance tax, and other taxes included in the Affordable Care Act. S. 80, The Jobs and Premium Protection Act of 2019 S. 172/H.R. 1398, The Health Insurance Tax Relief Act of 2019 H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 2213/S. 978, The Work Opportunity Tax Credit and Jobs Act of 2019 S. 1498, The Chronic Disease Management Act of 2019
Department of Defense Climate Resiliency and Readiness Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to health savings accounts, the health insurance tax, and other taxes included in the Affordable Care Act. S. 80, The Jobs and Premium Protection Act of 2019 S. 172/H.R. 1398, The Health Insurance Tax Relief Act of 2019 H.R. 2213/S. 978, The Work Opportunity Tax Credit and Jobs Act of 2019 S. 1498, The Chronic Disease Management Act of 2019
STOP Surprise Medical Bills Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinates of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
STOP Surprise Medical Bills Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinates of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
STOP Surprise Medical Bills Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing. H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinates of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Health Insurance Tax Relief Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to health savings accounts, the health insurance tax, and other taxes included in the Affordable Care Act. S. 80, The Jobs and Premium Protection Act of 2019 S. 172/H.R. 1398, The Health Insurance Tax Relief Act of 2019 H.R. 2213/S. 978, The Work Opportunity Tax Credit and Jobs Act of 2019 S. 1498, The Chronic Disease Management Act of 2019
Health Insurance Tax Relief Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to health savings accounts, the health insurance tax, and other taxes included in the Affordable Care Act. S. 80, The Jobs and Premium Protection Act of 2019 S. 172/H.R. 1398, The Health Insurance Tax Relief Act of 2019 H.R. 2213/S. 978, The Work Opportunity Tax Credit and Jobs Act of 2019 S. 1498, The Chronic Disease Management Act of 2019
Health Insurance Tax Relief Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to health savings accounts, the health insurance tax, and other taxes included in the Affordable Care Act. S. 80, The Jobs and Premium Protection Act of 2019 S. 172/H.R. 1398, The Health Insurance Tax Relief Act of 2019 H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 2213/S. 978, The Work Opportunity Tax Credit and Jobs Act of 2019 S. 1498, The Chronic Disease Management Act of 2019
Health Insurance Tax Relief Act of 2019
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to health savings accounts, the health insurance tax, and other taxes included in the Affordable Care Act. S. 80, The Jobs and Premium Protection Act S. 172/H.R. 1398, The Health Insurance Tax Relief Act of 2019
Lower Health Care Costs Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 The Prescription Drug Pricing Reduction Act of 2019 (no bill number assigned)
Lower Health Care Costs Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing. H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinates of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Lower Health Care Costs Act
Client: CVS HEALTH (AND SUBSIDIARIES) · Firm: CVS HEALTH (AND SUBSIDIARIES)
Issues related to employer, small group and individual insurance markets, including surprise billing. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinates of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S.2543, The Prescription Drug Pricing Reduction Act of 2019 S.2751, The Patient Access to ESRD New Innovate Device Act of 2019
Issues related to barriers to generic drug and biosmiliar market entry. H.R. 985, The Fair Access for Safe and Timely Generics Act of 2019 H.R. 1865, Further Consolidated Appropriations Act, 2020 S. 64, The Preserve Access to Affordable Generics Act of 2019 S. 340/H.R. 965, The Creating and Restoring Equal Access to Equivalent Samples Act of 2019 H.R. 1499, The Protecting Consumer Access to Generic Drugs Act of 2019 S. 659, The Biologic Patent Transparency Act of 2019
Issues related to implementation and changes to the Affordable Care Act.
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, The Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Issues related to the competitive nature of the pharmacy benefit management industry. H.R. 2376/S. 1227, The Prescription Pricing for the People Act of 2019 S. 2543, The Prescription Drug Pricing Reduction Act of 2019
Issues related to health savings accounts, the health insurance tax, and other taxes included in the Affordable Care Act. S. 80, The Jobs and Premium Protection Act of 2019 S. 172/H.R. 1398, The Health Insurance Tax Relief Act of 2019 H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 2213/S. 978, The Work Opportunity Tax Credit and Jobs Act of 2019 S. 1498, The Chronic Disease Management Act of 2019
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
CVS HEALTH (AND SUBSIDIARIES) via CVS HEALTH (AND SUBSIDIARIES)
2019 · third_quarter · Q3
Issues related to barriers to generic drug and biosmiliar market entry. H.R. 985, The Fair Access for Safe and Timely Generics Act of 2019 S. 64, The Preserve Access to Affordable Generics Act of 2019 S. 340/H.R. 965, The Creating and Restoring Equal Access to Equivalent Samples Act of 2019 H.R. 1499, The Protecting Consumer Access to Generic Drugs Act of 2019 S. 659, The Biologic Patent Transparency Act of 2019
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019 The Prescription Drug Pricing Reduction Act of 2019 (no bill number assigned)
Issues related to employer, small group and individual insurance markets, including surprise billing. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinates of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Issues related to health savings accounts, the health insurance tax, and other taxes included in the Affordable Care Act. S. 80, The Jobs and Premium Protection Act of 2019 S. 172/H.R. 1398, The Health Insurance Tax Relief Act of 2019 H.R. 2213/S. 978, The Work Opportunity Tax Credit and Jobs Act of 2019 S. 1498, The Chronic Disease Management Act of 2019
Issues related to implementation and changes to the Affordable Care Act.
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to HHS Proposed Rule Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 H.R. 3, The Lower Drug Costs Now Act of 2019 H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019 The Prescription Drug Pricing Reduction Act of 2019 (no bill number assigned)
Issues related to the competitive nature of the pharmacy benefit management industry. H.R. 2376/S. 1227, The Prescription Pricing for the People Act of 2019 The Prescription Drug Pricing Reduction Act of 2019 (no bill number assigned)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
CVS HEALTH (AND SUBSIDIARIES) via CVS HEALTH (AND SUBSIDIARIES)
2019 · second_quarter · Q2
Issues related to the competitive nature of the pharmacy benefit management industry. H.R. 2376/S. 1227, The Prescription Pricing for the People Act of 2019
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to HHS Proposed Rule Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020 S. 317/H.R. 1226, The Advancing Care for Exceptional Kids Act of 2019 S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019
Issues related to health savings accounts, the health insurance tax, and other taxes included in the Affordable Care Act. S. 80, The Jobs and Premium Protection Act of 2019 S. 172/H.R. 1398, The Health Insurance Tax Relief Act of 2019 H.R. 2213/S. 978, The Work Opportunity Tax Credit and Jobs Act of 2019 S. 1498, The Chronic Disease Management Act of 2019
Issues related to employer, small group and individual insurance markets, including surprise billing. H.R. 3107, The Improving Seniors Timely Access to Care Act of 2019 H.R. 3630, The No Surprises Act of 2019 S. 657, The Drug Price Transparency Act of 2019 S. 1323, The Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinates of Health Act of 2019 S. 1531, The Stopping the Outrageous Practice Of Surprise Medical Bills Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Issues related to barriers to generic drug and biosmiliar market entry including pay-for-delay and REMS. H.R. 985, The Fair Access for Safe and Timely Generics Act of 2019 S. 64, The Preserve Access to Affordable Generics Act of 2019 S. 340/H.R. 965, The Creating and Restoring Equal Access to Equivalent Samples Act of 2019 H.R. 1499, The Protecting Consumer Access to Generic Drugs Act of 2019 S. 659, The Biologic Patent Transparency Act of 2019
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 1614/S. 724, The John S. McCain Opioid Addiction Prevention Act of 2019 H.R. 2113, The Prescription Drug Sunshine, Transparency, Accountability and Reporting Act of 2019 H.R. 2115, The Public Disclosure of Drug Pricing Act of 2019 H.R. 2296, The Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R. 3408, the Shop Rx Act of 2019 S. 1895, The Lower Health Care Costs Act of 2019
Issues related to implementation and changes to the Affordable Care Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE, Treasury, Dept of, White House Office
CVS HEALTH (AND SUBSIDIARIES) via CVS HEALTH (AND SUBSIDIARIES)
2019 · first_quarter · Q1
Issues related to barriers to generic drug and biosmiliar market entry including pay-for-delay and REMS. H.R. 985, The Fair Access for Safe and Timely Generics Act of 2019 S. 64, The Preserve Access to Affordable Generics Act of 2019 S. 340/H.R. 965, The Creating and Restoring Equal Access to Equivalent Samples Act of 2019 H.R. 1499, The Protecting Consumer Access to Generic Drugs Act of 2019 S. 659, The Biologic Patent Transparency Act of 2019
Issues related to implementation and changes to the Affordable Care Act.
Issues related to medication adherence, drug price transparency, and prescription drug abuse. H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019 H.R. 1614/S. 724, The John S. McCain Opioid Addiction Prevention Act of 2019
Issues related to health savings accounts, the health insurance tax, and other taxes included in the Affordable Care Act. S. 80, The Jobs and Premium Protection Act S. 172/H.R. 1398, The Health Insurance Tax Relief Act of 2019
Issues related to employer, small group and individual insurance markets, including surprise billing. S. 657, The Drug Price Transparency Act of 2019
Issues related to the Medicare Part D, Medicare Advantage, Medicaid, and ESRD programs. Issues related to HHS Proposed Rule Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain Pharmacy Benefit Manager Service Fees. Issues related to CMS Medicare Advantage Advance Rate Notice and Draft Call Letter for 2020. S. 317/H.R. 1226, The Advancing Care for Exceptional Kids Act of 2019 S. 476, The Creating Transparency to Have Drug Rebates Unlocked Act of 2019 H.R. 803/S. 988, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2019 H.R. 1034/S. 640, The Phair Pricing Act of 2019 H.R. 1035, The Prescription Drug Price Transparency Act of 2019
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
CVS HEALTH (AND SUBSIDIARIES) via CVS HEALTH (AND SUBSIDIARIES)
2018 · fourth_quarter · Q4
Issues related to prescription drug abuse, medication adherence, and drug price transparency. H.R. 1316, The Prescription Drug Price Transparency Act of 2017 H.R. 5343, The Prescription Transparency Act of 2018 H.R. 6, The SUPPORT for Patients and Communities Act of 2018
Issues related to barriers to generic drug and biosimilar market entry including pay-for-delay and REMS. S. 124, The Preserve Access to Affordable Generics Act of 2017 S.771/H.R. 1776, The Improving Access to Affordable Prescription Drugs Act of 2017 H.R. 2051, The Fair Access for Safe and Timely Generics Act of 2017 S. 974/H.R. 2212, The Creating and Restoring Equal Access to Equivalent Samples Act of 2017
Issues related to prescription drug abuse and Medicare Part D. S.413/H.R. 1039, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2017 H.R.1316, The Prescription Drug Price Transparency Act of 2017 H.R. 5958, The Phair Pricing Act of 2018 H.R. 4143/S. 2065, The Dialysis PATIENTS Demonstration Act of 2017
Issues related to CVS Health announced merger with Aetna.
Issues related to health savings accounts, the health insurance tax, and other taxes included in the Affordable Care Act. H.R. 5138, The Bipartisan HSA Improvement Act of 2018 H.R. 6199, Restoring Access to Medication and Modernizing Health Savings Accounts Act of 2018 H.R. 6311, Increasing Access to Lower Premium Plans and Expanding Health Savings Accounts Act of 2018
Issues related to implementation and changes to the Affordable Care Act.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA), White House Office
CVS HEALTH (AND SUBSIDIARIES) via CVS HEALTH (AND SUBSIDIARIES)
2018 · third_quarter · Q3
Issues related to barriers to generic drug and biosimilar market entry including pay-for-delay and REMS. S. 124, The Preserve Access to Affordable Generics Act of 2017 S.771/H.R. 1776, The Improving Access to Affordable Prescription Drugs Act of 2017 H.R. 2051, The Fair Access for Safe and Timely Generics Act of 2017 S. 974/H.R. 2212, The Creating and Restoring Equal Access to Equivalent Samples Act of 2017
Issues related to CVS Health announced merger with Aetna.
Issues related to prescription drug abuse, medication adherence, drug price transparency, and gag clauses. H.R. 1316, The Prescription Drug Price Transparency Act of 2017 S. 2553/H.R. 6144, The Know the Lowest Price Act of 2018 S. 2554/H.R. 6143, The Patient Right to Know Drug Prices Act of 2018 H.R. 5343, The Prescription Transparency Act of 2018 H.R. 6, The SUPPORT for Patients and Communities Act of 2018 S. 2680, The Opioids Crisis Response Act
CVS HEALTH (AND SUBSIDIARIES) via CVS HEALTH (AND SUBSIDIARIES)
2018 · second_quarter · Q2
Issues related to prescription drug abuse and Medicare Part D. S.413/H.R. 1039, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2017 H.R.1316, The Prescription Drug Price Transparency Act of 2017 S. 2460/H.R. 3528, The Every Prescription Conveyed Securely Act of 2017 S. 2553/H.R. 6144, The Know the Lowest Price Act of 2018 H.R. 4841, The Standardizing Electronic Prior Authorization for Safe Prescribing Act H.R. 5958, The Phair Pricing Act of 2018
Issues related to health savings accounts, the health insurance tax and other taxes included in the Affordable Care Act. H.R. 5138, The Bipartisan HSA Improvement Act of 2018 H.R. 5963, To delay the reimposition of the annual fee on health insurance providers until after 2020
CVS HEALTH (AND SUBSIDIARIES) via CVS HEALTH (AND SUBSIDIARIES)
2018 · first_quarter · Q1
Issues related to barriers to generic drug and biosimilar market entry including pay-for-delay and REMS. S. 124, The Preserve Access to Affordable Generics Act of 2017 S.771/H.R. 1776, The Improving Access to Affordable Prescription Drugs Act of 2017 H.R. 2051, The Fair Access for Safe and Timely Generics Act of 2017 S. 974/H.R. 2212, The Creating and Restoring Equal Access to Equivalent Samples Act of 2017
Issues related to prescription drug abuse, medication adherence, generic drug approvals, biologic exclusivity periods, drug price transparency, and gag clauses. H.R.1316, The Prescription Drug Price Transparency Act of 2017 S. 778/H.R. 1854, The Prescription Drug Monitoring Act of 2017 S. 2460/H.R. 3528, The Every Prescription Conveyed Safely Act of 2017 S.892/H.R. 4408, The Opioid Addiction Prevention Act of 2017 S. 2456 / H.R. 5311, The CARA 2.0 Act of 2018 H.R. 4482, The Opioid Abuse Deterrence, Research, and Recovery Act of 2017 S. 2553, The Know the Lowest Price Act of 2018 S. 2554, The Patient Right to Know Drug Prices Act of 2018 H.R. 5343, The Prescription Transparency Act of 2018
CVS HEALTH (AND SUBSIDIARIES) via CVS HEALTH (AND SUBSIDIARIES)
2017 · fourth_quarter · Q4
Issues related to CVS Health announced merger with Aetna.
Issues related to corporate tax reform, health savings accounts, and taxes included in the Affordable Care Act. H.R.1, The Tax Cuts and Jobs Act H.R. 4620, The Protecting Families and Small Businesses Act of 2017
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA), White House Office
CVS HEALTH (AND SUBSIDIARIES) via CVS HEALTH (AND SUBSIDIARIES)
2017 · third_quarter · Q3
Issues related to corporate tax reform and taxes included in the Affordable Care Act.
Issues related to the Telephone Consumer Protection Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA), White House Office
CVS HEALTH (AND SUBSIDIARIES) via CVS HEALTH (AND SUBSIDIARIES)
2017 · second_quarter · Q2
Issues related to the Telephone Consumer Protection Act.
Issues related to corporate tax reform. S.638/H.R.1296, The Promoting More American Manufacturing Jobs Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA), White House Office
Issues related to health savings accounts, the health insurance tax and other taxes included in the Affordable Care Act. H.R. 5138, The Bipartisan HSA Improvement Act of 2018 H.R. 6199, Restoring Access to Medication and Modernizing Health Savings Accounts Act of 2018 H.R. 6311, Increasing Access to Lower Premium Plans and Expanding Health Savings Accounts Act of 2018
Issues related to implementation and changes to the Affordable Care Act.
Issues related to prescription drug abuse and Medicare Part D. S.413/H.R. 1039, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2017 H.R.1316, The Prescription Drug Price Transparency Act of 2017 S. 2553/H.R. 6144, The Know the Lowest Price Act of 2018 H.R. 5958, The Phair Pricing Act of 2018 H.R. 4143/S. 2065, The Dialysis PATIENTS Demonstration Act of 2017
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA), White House Office
Issues related to prescription drug abuse, medication adherence, drug price transparency, and gag clauses. H.R. 1316, The Prescription Drug Price Transparency Act of 2017 S. 778/H.R. 1854, The Prescription Drug Monitoring Act of 2017 S. 2460/H.R. 3528, The Every Prescription Conveyed Securely Act of 2017 S. 892/H.R. 4408, The Opioid Addiction Prevention Act of 2017 S. 2456/H.R. 5311, The CARA 2.0 Act of 2018 S. 2553/H.R. 6144, The Know the Lowest Price Act of 2018 S. 2554/H.R. 6143, The Patient Right to Know Drug Prices Act of 2018 H.R. 5343, The Prescription Transparency Act of 2018 H.R. 6, The SUPPORT for Patients and Communities Act of 2018 H.R. 6133, The Informing Opioid Prescribing Through Evidence-Based Guidelines Act of 2018
Issues related to implementation and changes to the Affordable Care Act.
Issues related to CVS Health announced merger with Aetna.
Issues related to barriers to generic drug and biosimilar market entry including pay-for-delay and REMS. S. 124, The Preserve Access to Affordable Generics Act of 2017 S.771/H.R. 1776, The Improving Access to Affordable Prescription Drugs Act of 2017 H.R. 2051, The Fair Access for Safe and Timely Generics Act of 2017 S. 974/H.R. 2212, The Creating and Restoring Equal Access to Equivalent Samples Act of 2017
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Issues related to implementation and changes to the Affordable Care Act.
Issues related to health savings accounts, the health insurance tax and other taxes included in the Affordable Care Act. S. 1859, the Healthcare Tax Relief Act of 2017 H.R. 95, Making Further Continuing Appropriations for the fiscal year ending September 30, 2018 H.R. 4620, the Protecting Families and Small Business Act of 2018 H.R. 5138, the Bipartisan HSA Improvement Act of 2018
Issues related to CVS Health announced merger with Aetna.
Issues related to prescription drug abuse, Medicare Part D, and Medicare payment for home infusion. S.413/H.R. 1039, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2017 H.R.1316, The Prescription Drug Price Transparency Act of 2017 S. 2460/H.R. 3528, The Every Prescription Conveyed Safely Act of 2017 S. 1738/H.R. 3163, The Medicare Home Infusion Therapy Act of 2017 H.R. 3178, The Medicare Part B Improvement Act of 2017 S. 2553, The Know the Lowest Price Act of 2018 H.R. 4841, The Standardizing Electronic Prior Authorization for Safe Prescribing Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE